Total Payments
$501,159
2023 Payments
$6,039
Companies
19
Transactions
514
Payment Breakdown by Category
Other$430,777 (86.0%)
Travel$42,370 (8.5%)
Consulting$15,267 (3.0%)
Food & Beverage$12,589 (2.5%)
Education$156.24 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $430,777 | 157 | 86.0% |
| Travel and Lodging | $42,370 | 124 | 8.5% |
| Consulting Fee | $15,267 | 16 | 3.0% |
| Food and Beverage | $12,589 | 211 | 2.5% |
| Education | $156.24 | 6 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $195,071 | 142 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $75,672 | 68 | $0 (2023) |
| PFIZER INC. | $52,608 | 66 | $0 (2019) |
| Regeneron Healthcare Solutions, Inc. | $51,320 | 57 | $0 (2019) |
| Lilly USA, LLC | $49,847 | 57 | $0 (2021) |
| Amgen Inc. | $28,882 | 40 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $19,265 | 17 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $18,081 | 24 | $0 (2019) |
| PORTOLA PHARMACEUTICALS, INC. | $8,390 | 11 | $0 (2018) |
| BIOTRONIK INC. | $418.76 | 6 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $6,039 | 5 | E.R. Squibb & Sons, L.L.C. ($5,899) |
| 2022 | $26,384 | 17 | E.R. Squibb & Sons, L.L.C. ($26,314) |
| 2021 | $10,885 | 8 | Boehringer Ingelheim Pharmaceuticals, Inc. ($9,071) |
| 2020 | $8,947 | 11 | Lilly USA, LLC ($5,100) |
| 2019 | $141,804 | 154 | Boehringer Ingelheim Pharmaceuticals, Inc. ($43,773) |
| 2018 | $137,662 | 155 | Boehringer Ingelheim Pharmaceuticals, Inc. ($53,305) |
| 2017 | $169,436 | 164 | Boehringer Ingelheim Pharmaceuticals, Inc. ($85,246) |
All Payment Transactions
514 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/17/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,645.00 | General |
| Category: Cardiovascular | ||||||
| 09/21/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Cardiovascular | ||||||
| 04/21/2023 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $2,025.00 | General |
| 04/20/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $104.31 | General |
| Category: Cardiovascular | ||||||
| 02/27/2023 | ShockWave Medical, Inc | SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER (Device) | Food and Beverage | In-kind items and services | $139.74 | General |
| Category: Lithoplasty | ||||||
| 12/13/2022 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $300.00 | General |
| 11/09/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,655.00 | General |
| Category: Cardiovascular | ||||||
| 11/09/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,655.00 | General |
| Category: Cardiovascular | ||||||
| 11/08/2022 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $119.93 | General |
| Category: Cardiovascular | ||||||
| 11/01/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Travel and Lodging | Cash or cash equivalent | $2,344.63 | General |
| Category: Cardiovascular | ||||||
| 11/01/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $91.97 | General |
| Category: Cardiovascular | ||||||
| 10/27/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $124.99 | General |
| Category: Cardiovascular | ||||||
| 10/12/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Travel and Lodging | Cash or cash equivalent | $100.00 | General |
| Category: Cardiovascular | ||||||
| 10/10/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $69.79 | General |
| 09/13/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,655.00 | General |
| Category: Cardiovascular | ||||||
| 08/02/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,655.00 | General |
| Category: Cardiovascular | ||||||
| 07/21/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Travel and Lodging | Cash or cash equivalent | $995.04 | General |
| Category: Cardiovascular | ||||||
| 07/21/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $109.37 | General |
| Category: Cardiovascular | ||||||
| 04/19/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,655.00 | General |
| Category: Cardiovascular | ||||||
| 03/31/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $73.45 | General |
| Category: Cardiovascular | ||||||
| 03/29/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,655.00 | General |
| Category: Cardiovascular | ||||||
| 03/09/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $124.89 | General |
| Category: Cardiovascular | ||||||
| 12/07/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,200.00 | General |
| Category: DIABETES | ||||||
| 11/22/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,200.00 | General |
| Category: DIABETES | ||||||
| 11/16/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,200.00 | General |
| Category: DIABETES | ||||||
About Dr. William Bommer, M.D
Dr. William Bommer, M.D is a Cardiovascular Disease healthcare provider based in Sacramento, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/10/2005. The National Provider Identifier (NPI) number assigned to this provider is 1326029794.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Bommer, M.D has received a total of $501,159 in payments from pharmaceutical and medical device companies, with $6,039 received in 2023. These payments were reported across 514 transactions from 19 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($430,777).
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Sacramento, CA
- Active Since 11/10/2005
- Last Updated 01/19/2010
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1326029794
Products in Payments
- JARDIANCE (Drug) $239,813
- ELIQUIS (Drug) $125,606
- PRALUENT ALIROCUMAB INJECTION (Biological) $32,456
- Repatha (Biological) $28,806
- PRALUENT (Drug) $19,265
- PRALUENT (Biological) $18,864
- ENTRESTO (Drug) $18,081
- BEVYXXA (Drug) $8,390
- PRADAXA (Drug) $3,321
- LifeVest (Device) $247.30
- CAMZYOS (Drug) $224.24
- XARELTO (Drug) $220.68
- BRILINTA (Drug) $218.44
- Quadra Assura CRT Defibrillator (Device) $141.10
- SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER (Device) $139.74
- OPSUMIT MACITENTAN (Drug) $136.36
- VYNDAQEL (Drug) $123.97
- RESONATE (Device) $120.66
- Corlanor (Drug) $62.33
- SAMSCA (Drug) $49.37
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Sacramento
Jason Rogers, M.d, M.D
Cardiovascular Disease — Payments: $4.4M
Cardiovascular Disease $4.4M
Gagan Singh, M.d, M.D
Cardiovascular Disease — Payments: $1.2M
Cardiovascular Disease $1.2M
Dr. Edris Aman, M.d, M.D
Cardiovascular Disease — Payments: $361,130
Cardiovascular Disease $361,130
Munir Janmohamed, Md, MD
Cardiovascular Disease — Payments: $309,883
Cardiovascular Disease $309,883
Jeffrey Southard, M.d, M.D
Cardiovascular Disease — Payments: $280,346
Cardiovascular Disease $280,346
Gurpreet Sodhi, M.d, M.D
Cardiovascular Disease — Payments: $218,917
Cardiovascular Disease $218,917